Stock listing
Frankfurt:V30 Apotea AB Aktie
German listing (Frankfurt) of Apotea AB · home listing Stockholm:APOTEA
Follow Apotea AB into a list and get an email when it puts out news.
Share price · FWB:V30
€9.00 EUR -0.09 (-0.9%)
Close on Nov 20, 2026
- Day range
- €9.00 – €9.05 EURNov 20, 2026
- Market cap
- €944.2M EURAt the close on Nov 20, 2026 · price × 105.0M shares outstanding
- 52-week range
- €5.04 – €9.43 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €3,156 EURMedian day 0 shares · 47 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Stockholm:APOTEA · Home | 101.20 SEK | -0.10 (-0.1%) | 94,277 | 101.20 | 101.70 | 100.20 | 101.30 | Close on Nov 20, 2026 |
| Frankfurt:V30 | €8.995 EUR | -0.085 (-0.9%) | — | €9.05 | €9.05 | €8.995 | €9.08 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:V30 · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €9.317 | +0.081 | +0.9% | €9.421 | €9.427 | €9.28 | 0 | |
| €9.236 | +0.614 | +7.1% | €8.921 | €9.379 | €8.72 | 232 | |
| €8.622 | +0.073 | +0.9% | €8.619 | €8.647 | €8.505 | 232 | |
| €8.549 | +0.112 | +1.3% | €8.532 | €8.652 | €8.413 | 0 | |
| €8.437 | +0.048 | +0.6% | €8.433 | €8.448 | €8.397 | 0 | |
| €8.389 | +0.007 | +0.1% | €8.39 | €8.39 | €8.389 | 0 | |
| €8.382 | +0.152 | +1.8% | €8.393 | €8.393 | €8.367 | 0 | |
| €8.23 | +0.007 | +0.1% | €8.322 | €8.362 | €8.23 | 0 | |
| €8.223 | +0.02 | +0.2% | €8.219 | €8.29 | €8.181 | 100 | |
| €8.203 | +0.054 | +0.7% | €8.218 | €8.223 | €8.203 | 13,788 | |
| €8.149 | +0.017 | +0.2% | €8.096 | €8.167 | €8.05 | 0 | |
| €8.132 | +0.165 | +2.1% | €8.092 | €8.135 | €8.08 | 0 | |
| €7.967 | -0.144 | -1.8% | €7.977 | €7.991 | €7.967 | 0 | |
| €8.111 | -0.071 | -0.9% | €8.139 | €8.23 | €8.031 | 0 | |
| €8.182 | +0.164 | +2.0% | €8.175 | €8.185 | €8.163 | 0 | |
| €8.018 | +0.067 | +0.8% | €8.066 | €8.122 | €8.018 | 0 | |
| €7.951 | +0.182 | +2.3% | €7.865 | €7.997 | €7.822 | 0 | |
| €7.769 | +0.093 | +1.2% | €7.788 | €7.788 | €7.713 | 0 | |
| €7.676 | +0.036 | +0.5% | €7.681 | €7.728 | €7.618 | 0 | |
| €7.64 | -0.028 | -0.4% | €7.581 | €7.733 | €7.565 | 0 | |
| €7.668 | +0.141 | +1.9% | €7.698 | €7.698 | €7.621 | 2,884 | |
| €7.527 | +0.113 | +1.5% | €7.441 | €7.62 | €7.341 | 1,200 | |
| €7.414 | +0.101 | +1.4% | €7.294 | €7.437 | €7.257 | 0 | |
| €7.313 | +0.018 | +0.2% | €7.229 | €7.422 | €7.193 | 0 | |
| €7.295 | -0.064 | -0.9% | €7.241 | €7.32 | €7.197 | 0 | |
| €7.359 | -0.055 | -0.7% | €7.422 | €7.422 | €7.304 | 0 | |
| €7.414 | -0.188 | -2.5% | €7.434 | €7.513 | €7.381 | 0 | |
| €7.602 | +0.051 | +0.7% | €7.698 | €7.797 | €7.576 | 0 | |
| €7.551 | +0.118 | +1.6% | €7.626 | €7.627 | €7.529 | 0 | |
| €7.433 | +0.088 | +1.2% | €7.405 | €7.444 | €7.355 | 0 | |
| €7.345 | +0.073 | +1.0% | €7.323 | €7.456 | €7.193 | 1,000 | |
| €7.272 | -0.053 | -0.7% | €7.294 | €7.36 | €7.272 | 0 | |
| €7.325 | -0.102 | -1.4% | €7.345 | €7.345 | €7.284 | 0 | |
| €7.427 | +0.312 | +4.4% | €7.328 | €7.537 | €7.313 | 0 | |
| €7.115 | +0.193 | +2.8% | €7.14 | €7.163 | €7.097 | 0 | |
| €6.922 | -0.002 | 0.0% | €7.039 | €7.07 | €6.922 | 1,276 | |
| €6.924 | +0.261 | +3.9% | €6.853 | €7.042 | €6.852 | 0 | |
| €6.663 | +0.022 | +0.3% | €6.678 | €6.71 | €6.566 | 0 | |
| €6.641 | +0.071 | +1.1% | €6.613 | €6.749 | €6.556 | 0 | |
| €6.57 | -0.085 | -1.3% | €6.608 | €6.628 | €6.514 | 0 | |
| €6.655 | -0.013 | -0.2% | €6.651 | €6.667 | €6.644 | 0 | |
| €6.668 | -0.313 | -4.5% | €6.739 | €6.759 | €6.652 | 0 | |
| €6.981 | +0.137 | +2.0% | €6.923 | €7.022 | €6.912 | 0 | |
| €6.844 | -0.033 | -0.5% | €6.853 | €6.86 | €6.833 | 0 | |
| €6.877 | -0.151 | -2.1% | €6.882 | €6.889 | €6.857 | 0 | |
| €7.028 | +0.016 | +0.2% | €7.049 | €7.075 | €6.958 | 2,004 | |
| €7.012 | +0.148 | +2.2% | €6.862 | €7.021 | €6.832 | 0 | |
| €6.864 | -0.013 | -0.2% | €6.922 | €6.946 | €6.864 | 0 | |
| €6.877 | -0.022 | -0.3% | €6.882 | €6.882 | €6.877 | 0 | |
| €6.899 | -0.058 | -0.8% | €6.925 | €7.008 | €6.899 | 0 | |
| €6.957 | +0.10 | +1.5% | €6.977 | €6.977 | €6.945 | 58 | |
| €6.857 | +0.085 | +1.3% | €6.76 | €6.901 | €6.691 | 0 | |
| €6.772 | +0.024 | +0.4% | €6.774 | €6.776 | €6.772 | 0 | |
| €6.748 | +0.141 | +2.1% | €6.755 | €6.779 | €6.748 | 0 | |
| €6.607 | -0.119 | -1.8% | €6.615 | €6.62 | €6.606 | 0 | |
| €6.726 | +0.022 | +0.3% | €6.747 | €6.793 | €6.72 | 0 | |
| €6.704 | +0.144 | +2.2% | €6.699 | €6.719 | €6.682 | 0 |
- Ticker
- Frankfurt:V30
- Asset type
- Stock
- Sector
- Retail & consumer services
- Industry
- Retail & e-commerce
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Jul 17, 2026
Apotea: Continued strong profitability and stable growth
Latest earnings call · Nov 5, 2026
Apotea (Stockholm:APOTEA) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Jul 17, 2026
Q2 2026 Earnings Presentation
Earnings · 12 slides
Latest news
Apotea: Continued strong profitability and stable growth
Jul 17, 2026
Closed €7.19 (+6.6%) on Jul 17, 2026
APOTEA: Q1 2026 delivered strong growth, higher margins, and a solid net cash position
Apr 29, 2026
Closed €6.95 (+14.6%) on Apr 29, 2026
Apotea publishes annual and sustainability report for the financial year 2025
Apr 17, 2026
Closed €6.12 (-1.0%) on Apr 17, 2026
APOTEA: Q4 revenue grew 7% but margins fell on campaign intensity and Varberg ramp-up costs
Feb 4, 2026
Closed €5.74 (-2.7%) on Feb 5, 2026
Apotea has recruited Joanna Hummel to accelerate the company’s growth initiatives
Jan 28, 2026
Closed €5.89 (+0.3%) on Jan 28, 2026
Apotea Preliminary Q4 Oper Margin Below Targets At 1.3%
Jan 21, 2026
Closed €6.21 (-19.6%) on Jan 21, 2026
Update regarding the fourth quarter of 2025
Jan 20, 2026
Closed €6.21 (-19.6%) on Jan 21, 2026
Invitation to Apotea’s presentation of the year-end report 2025
Dec 18, 2025
Closed €8.17 (-4.0%) on Dec 18, 2025
Apotea Board Member Sells SEK 43.4 Mln Of Shares On Dec 4
Dec 4, 2025
Closed €7.90 (-0.2%) on Dec 4, 2025
Apotea AB on 6ix
- Industry
- Retail & e-commerce
- News releases
- 9 in the last 12 months · 14 in all · newest Jul 17, 2026 · oldest 2025
- Calls
- 8 calls with a replay · 8 with a transcript · latest Nov 5, 2026
- Decks
- 7 decks · latest Jul 17, 2026
Where Apotea AB is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Stockholm:APOTEA · Home listing | Stockholm | Sweden | SEK |
| gettex:V30 | gettex | Germany | EUR |
| Tradegate:V30 | Tradegate | Germany | EUR |
| Frankfurt:V30 · This page | Frankfurt | Germany | EUR |
| Stuttgart:V30 | Stuttgart | Germany | EUR |
| LS Exchange:A40WTZ | LS Exchange | Germany | EUR |
| Dusseldorf:V30 | Dusseldorf | Germany | EUR |
| Munich:V30 | Munich | Germany | EUR |
| Lang & Schwarz:A40WTZ | Lang & Schwarz | Germany | EUR |
| Turquoise:APOTES | Turquoise | United Kingdom | SEK |
Valuation
P/E 40.7× against a median of 15.5×: the highest of 10 Retail & e-commerce companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- 10.42B SEK
- P/E
- 40.7×
- EV/sales
- 1.3×
- EV/EBITDA
- 18.9×
- Price/book
- 10.2×
- Gross margin
- 26.9%
- Operating margin
- 4.3%
- Net margin
- 3.3%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Retail & e-commerce: the 10 companies nearest in size, of 506 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Apotea AB · OMXSTO:APOTEA | US$1.03B | US$1.02B | 40.7× | 1.3× | 18.9× | 10.2× | 3.3% | 0.0× | n/a |
| Magazine Luiza S.A. · BMFBOVESPA:MGLU3 | US$1.07B | US$2.21B | n/a | 0.3× | 6.0× | 0.6× | −0.0% | 0.8× | n/a |
| Dis-Chem Pharmacies Limited · JSE:DCP | US$1.06B | US$1.41B | 19.0× | 0.6× | 7.6× | 3.1× | 2.3% | 1.1× | n/a |
| Moonpig Group PLC · LSE:MOON | US$1.05B | US$1.19B | 15.5× | 2.4× | 8.7× | n/a | 13.9% | n/a | n/a |
| Pet Valu Holdings Ltd. · TSX:PET | US$1.04B | US$1.59B | 14.8× | 1.9× | 8.6× | 16.1× | 8.4% | 8.8× | 0.40 |
| PT Daya Intiguna Yasa Tbk · IDX:MDIY | US$1.03B | US$1.15B | 15.5× | 2.2× | 7.3× | 4.1× | 13.0% | 0.6× | n/a |
| FPT Digital Retail JSC · HOSE:FRT | US$1.03B | US$579.8M | 19.5× | 0.2× | 5.6× | 5.0× | 2.1% | 0.0× | n/a |
| PT MAP Aktif Adiperkasa Tbk · IDX:MAPA | US$973.3M | US$1.04B | 8.8× | 0.9× | 4.0× | 1.7× | 9.2% | 0.3× | n/a |
| Truworths International Limited · JSE:TRU | US$971.4M | US$1.20B | 6.4× | 1.0× | 4.9× | 1.7× | 12.2% | 0.7× | n/a |
| PT Mitra Adiperkasa Tbk · IDX:MAPI | US$959.9M | US$1.14B | 6.8× | 0.4× | 2.4× | 1.1× | 5.2% | 0.6× | n/a |
| Boozt AB · OMXSTO:BOOZT | US$955.1M | US$1.02B | 29.2× | 1.2× | 13.1× | 3.6× | 3.8% | 0.4× | n/a |
| Median of the others | US$1.03B | US$1.17B | 15.5× | 0.9× | 6.7× | 3.1× | 6.8% | 0.6× | 0.40 |
Forecasts
Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.
- Price target
- 105.50 SEK · Analysts' mean
- EPS, year to Dec 2026
- 2.92 · 2 analysts
- Revenue, year to Dec 2026
- 8.08B · 2 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Pär Svärdson | CEO |
| Johan Mårild | CFO |
| Sarah Ahnström | Deputy CEO/COO |
| Joanna Hummel | Chief Growth Officer |
| Stefan Eriksson | Deputy CEO/Organization and people |
Board
| Director | Role |
|---|---|
| Joanna Hummel | Chief Growth Officer |
| Pär Svärdson | CEO |
Events
- Next results
- Feb 4, 2027 (expected)
Calls
| Call | When | Status |
|---|---|---|
| Apotea (Stockholm:APOTEA) Q3 2026 Earnings Call | Thu, Nov 05, 2026 · 3:30 AM ET | Replay |
| Apotea (Stockholm:APOTEA) Q2 2026 Earnings Call | Fri, Jul 17, 2026 · 3:30 AM ET | Replay |
| Apotea (Stockholm:APOTEA) Q1 2026 Earnings Call | Wed, Apr 29, 2026 · 3:30 AM ET | Replay |
| Apotea (Stockholm:APOTEA) Q4 2025 Earnings Call | Wed, Feb 04, 2026 · 3:30 AM ET | Replay |
| Apotea (Stockholm:APOTEA) Q3 2025 Earnings Call | Thu, Nov 06, 2025 · 3:30 AM ET | Replay |
| Apotea (Stockholm:APOTEA) Q2 2025 Earnings Call | Fri, Jul 18, 2025 · 3:30 AM ET | Replay |
| Apotea (Stockholm:APOTEA) Q1 2025 Earnings Call | Thu, May 08, 2025 · 3:30 AM ET | Replay |
| Apotea (Stockholm:APOTEA) Q4 2024 Earnings Call | Thu, Feb 06, 2025 · 3:30 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 5, 2026 · Before open | +7.7% |
| Q2 2026 | Jul 17, 2026 · Before open | +7.9% |
| Q1 2026 | Apr 29, 2026 · Before open | +12.8% |
| Q4 2025 | Feb 4, 2026 · Before open | +4.8% |
| Q3 2025 | Nov 6, 2025 · Before open | +9.8% |
| Q2 2025 | Jul 18, 2025 · After close | +8.0% |
| Q1 2025 | May 8, 2025 · Before open | +4.0% |
| Q4 2024 | Feb 6, 2025 | +6.6% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2026 Earnings Presentation | Earnings | 12 slides | Jul 17, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 10 slides | Apr 29, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 14 slides | Feb 4, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 11 slides | Nov 6, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 11 slides | Jul 18, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 10 slides | May 8, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 14 slides | Feb 6, 2025 |
Financials
Annual, in SEK
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7.20B | 6.54B | 5.45B | 4.88B | 4.56B |
| Cost of revenue | 5.27B | 4.75B | 4.00B | 3.61B | 3.81B |
| Gross profit | 1.94B | 1.79B | 1.45B | 1.27B | 750.3M |
| Research and development | 597.6K | ||||
| Operating income | 298.2M | 265.8M | 113.6M | 49.0M | 133.6M |
| Depreciation and amortization | 162.3M | 129.6M | 112.7M | 70.0M | 49.9M |
| EBITDA | 460.5M | 395.4M | 226.3M | 119.0M | 183.5M |
| Interest expense | 12.0M | 5.30M | 6.30M | 3.80M | |
| Income before tax | 289.8M | 264.7M | 108.7M | 31.0M | 130.4M |
| Income tax | 63.5M | 52.7M | 26.4M | 12.7M | 25.9M |
| Net income | 228.7M | 214.9M | 87.0M | 19.9M | 104.5M |
| Earnings per share, basic | 2.20 | 2.09 | 0.85 | 0.19 | 1.03 |
| Earnings per share, diluted | 2.20 | 2.09 | 0.85 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash and equivalents | 30.6M | 27.3M | 19.1M | 18.2M | 81.4M |
| Receivables | 355.4M | 358.8M | 289.4M | 246.0M | 230.7M |
| Inventory | 651.9M | 562.3M | 410.1M | 390.0M | 338.3M |
| Current assets | 1.12B | 1.02B | 781.5M | 721.3M | 710.8M |
| Property, plant and equipment | 505.8M | 388.0M | 299.2M | ||
| Goodwill | 30.5M | 32.0M | 32.5M | 57.5M | 5.48M |
| Total assets | 1.98B | 1.63B | 1.34B | 1.25B | 1.02B |
| Accounts payable | 584.1M | 559.4M | 546.1M | 463.8M | 435.7M |
| Current liabilities | 871.5M | 880.8M | 756.7M | 716.4M | 559.5M |
| Total debt | 331.0M | 21.8M | 25.9M | 332.7M | 144.3M |
| Total liabilities | 1.12B | 991.7M | 911.4M | 897.5M | 685.0M |
| Shareholders' equity | 844.0M | 615.2M | 403.7M | 327.5M | 339.8M |
| Shares outstanding | 104.1M | 102.6M | 104.1M | 104.1M | 101.9M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash from operations | 333.3M | 206.2M | 215.8M | 31.5M | 227.3M |
| Capital spending | -213.0M | -162.8M | -119.9M | -142.1M | -81.5M |
| Free cash flow | 120.3M | 43.4M | 95.9M | -110.6M | 145.8M |
| Cash from investing | -214.5M | -163.7M | -121.6M | -141.4M | -81.6M |
| Cash from financing | -115.3M | -34.2M | -93.3M | 46.3M | -78.4M |
| Dividends paid | -28.5M | -28.4M | |||
| Change in cash | 3.50M | 8.30M | 900.0K | -63.5M | 67.3M |
Cap table
Built by 6ix from Apotea AB’s releases
- Common shares
- 104,070,966
- Fully diluted
- 104,070,966
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 104,070,966 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 104,070,966 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Joanna Hummel | Chief Growth Officer · Since at least Jan 28, 2026 |
| Johan Mårild | CFO · Since at least Jul 17, 2026 |
| Pär Svärdson | CEO · Since at least Jul 17, 2026 |
| Sarah Ahnström | Deputy CEO/COO · Since at least Jul 17, 2026 |
| Stefan Eriksson | Deputy CEO/Organization and people · Since at least Jul 17, 2026 |
Log in to ask 6ix AI your own questions about Apotea AB.